GLYCOMARK, INC.
NEW YORK, NY

GLYCOMARK: IT’S WHAT YOU DON’T KNOW. High blood glucose and glycemic variability can not only affect how you feel, they can cause serious health issues. The GlycoMark test is a non-fasting blood glucose test for people with diabetes that provides information that A1C and other tests can’t. More complete data means greater control of your diabetes. Hit your mark with GlycoMark. GlycoMark. The more you know . . . Glycemic variability can threaten your health, even when your diabetes seems to be under control. GlycoMark is an indicator of recent glycemic control that is associated with average daily peak glucose levels, not a three-month average level. Having more complete information can make diabetes management more effective. GlycoMark. It’s what you should know. Now. Is GlycoMark right for you? Know the score. Maintaining your target blood glucose level is the key to managing diabetes. It’s about the way you feel. And the way you live. GlycoMark provides information about average daily peak glucose levels that other tests don’t show. Is GlycoMark right for you? Talk to your doctor today. GlycoMark is the only specific indicator of hyperglycemia and glycemic variability among other tests used for monitoring glucose control, such as A1C and fructosamine. It tells you more than you can learn from A1C and fasting blood glucose testing. Use GlycoMark in devising patient-personalized strategies for hitting and holding targeted blood glucose levels. Look closer, here. Over 14% of A1C tests may not be accurately describing glycemic control due to many conditions that can alter the results. And because it is an average, it can mask variability—highs and lows in your glucose levels. Bob and Susan have similar A1C numbers in a good range, but their glycemic variability is quite different. See how GlycoMark evens the field. Hiro has more than ten years of experience in the biotech industry, specifically with diabetes and its related complications. He has worked in research and analysis of regulatory and industry developments in the U.S. pharmaceutical and biotech market. Hiro has extensive global business development experience in Europe, Asia, the Middle East and Latin America. Hiro holds a Master’s degree in Biotechnology from Columbia University. Jeff Dahlen, Ph.D., has worked in the in-vitro diagnostics industry for more than 15 years. Prior to joining GlycoMark, he held leadership positions in assay development, clinical affairs, regulatory affairs, medical affairs, and scientific affairs at Biosite, Oculir, and Accumetrics. Jeff holds a Bachelor of Science degree in Engineering from the University of Illinois and a Ph.D. in Biomedical Sciences (Biochemistry and Molecular Biology) from the University of New Mexico. Business Development Executive, Diabetes Group Carl Abbatecola has over 10 years’ experience in the laboratory industry. He started his career with a Miami-based anatomical pathology laboratory specializing in early cancer detection. Carl expanded his laboratory experience as leader of Women’s Health Initiatives for Clinical Pathology Laboratory Southeast. Carl joined GlycoMark, Inc. in 2012. He manages the company’s sales efforts in the southern United States. Lauren brings extensive commercial and clinical diagnostics experience to GlycoMark, with over 20 years of sales, distribution and marketing management experience with Roche Diagnostics, Biosite, Accumetrics and is co-Founder of L3 Healthcare. Lauren focuses on clinical market education and awareness of the GlycoMark Test to help advance the care of patients with diabetes to a broader market segment. She holds a Bachelor’s degree in international business from the University of South Florida. Kirsten possesses over ten years of management and marketing experience. She has worked with L3 since 2013 and provides world-class support and project management spanning graphic design, tradeshow management, event planning and the development of marketing, corporate and investor materials. Kirsten is currently in a Bachelor’s transfer program at San Diego City College. The GlycoMark test is an FDA-cleared, non-fasting serum or plasma test for monitoring blood glucose variability in people with diabetes. The GlycoMark test provides quantitative measurement of 1,5-anhydroglucitol (1,5-AG) in serum or plasma. The test is for professional use, and is indicated for the intermediate term monitoring of glycemic control in people with diabetes. GLYCOMARK: IT’S WHAT YOU DON’T KNOW. High blood glucose and glycemic variability can not only affect how you feel, they can cause serious health issues. The GlycoMark test is a non-fasting blood glucose test for people with diabetes that provides information that A1C and other tests can’t. More complete data means greater control of your diabetes. Hit your mark with GlycoMark. GlycoMark. The more you know . . . Glycemic variability can threaten your health, even when your diabetes seems to be under control. GlycoMark is an indicator of recent glycemic control that is associated with average daily peak glucose levels, not a three-month average level. Having more complete information can make diabetes management more effective. GlycoMark. It’s what you should know. Now. Is GlycoMark right for you? Know the score. Maintaining your target blood glucose level is the key to managing diabetes. It’s about the way you feel. And the way you live. GlycoMark provides information about average daily peak glucose levels that other tests don’t show. Is GlycoMark right for you? Talk to your doctor today. GlycoMark is the only specific indicator of hyperglycemia and glycemic variability among other tests used for monitoring glucose control, such as A1C and fructosamine. It tells you more than you can learn from A1C and fasting blood glucose testing. Use GlycoMark in devising patient-personalized strategies for hitting and holding targeted blood glucose levels. Look closer, here. Over 14% of A1C tests may not be accurately describing glycemic control due to many conditions that can alter the results. And because it is an average, it can mask variability—highs and lows in your glucose levels. Bob and Susan have similar A1C numbers in a good range, but their glycemic variability is quite different. See how GlycoMark evens the field.